Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure

Jake E Doiron^{1

2}, David J Lefer^{1

2}

Affiliations

¹ Cardiovascular Center of Excellence, School of Medicine, LSU Health Science Center, New Orleans, LA (J.E.D., D.J.L.).
² Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans (J.E.D., D.J.L.).

Free article

Editorial

Jake E Doiron et al. Circ Res. 2022.

Free article

. 2022 Jul 8;131(2):165-167.

doi: 10.1161/CIRCRESAHA.122.321392. Epub 2022 Jul 7.

Jake E Doiron^{1

2}, David J Lefer^{1

2}

¹ Cardiovascular Center of Excellence, School of Medicine, LSU Health Science Center, New Orleans, LA (J.E.D., D.J.L.).
² Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans (J.E.D., D.J.L.).

No abstract available

Keywords: cardiovascular disease; edema; heart failure; hospital; myocardial infarction.

Comment on

Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
Zhu D, Zhang Z, Zhao J, Liu D, Gan L, Lau WB, Xie D, Meng Z, Yao P, Tsukuda J, Christopher TA, Lopez BL, Gao E, Koch WJ, Wang Y, Ma XL. Zhu D, et al. Circ Res. 2022 Jul 8;131(2):e34-e50. doi: 10.1161/CIRCRESAHA.121.319976. Epub 2022 May 25. Circ Res. 2022. PMID: 35611695 Free PMC article.